Article
Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese.
Cancer medicine - 1 Dec 2023
Wei Bing, Zhao Jiadong, Li Jun, Feng Junnan, Sun Manman, Wang Zhizhong, Shi Chao, Yang Ke, Qin Yue, Zhang Jing, Ma Jie, Dong Hui
Abstract excerpt
BACKGROUD: Multiple studies have identified pathogenic germline variants in cancer susceptibility genes (CSGs) in Chinese lung cancer patients; however, accurate assessment of these variants' contributions to cancer predisposition is always hampered by the absence of data on the prevalence of these variants in the general population. It is necessary to conduct a large-scale case-control study to identify CSGs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
